Regeneron vision-threatening disease
Working with Regeneron to make a app that was completely accessable. Their programs target a number of mechanisms in retinal diseases in unique combinations with anti-Vascular Endothelial Growth Factor (VEGF) therapy, which employs Regeneron's proprietary Trap technology and is currently the standard-of-care for a number of retinal conditions.
See Project